Emcure Pharma IPO GMP, Review, Price, Allotment

0
Emcure IPO GMP

Emcure Pharma IPO description – Emcure is a leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. It is ranked as (i) the 12th largest pharmaceutical company in India and (ii) the largest pharmaceutical company in India in the gynecology, blood related and HIV antivirals therapeutic areas, based on sales in India in the FY2021. It is an R&D driven company with a differentiated product portfolio that includes orals, injectables and biologics, as well as an mRNA platform through which it is currently developing a COVID-19 vaccine.

Emcure’s products are sold across over 70 countries with a strong presence in Europe and Canada. The company has experienced rapid growth in recent years and it is one of the fastest growing pharmaceutical companies in India. Between the FY2019 and the FY2021, its total sales in India grew at a CAGR of 11.28% from INR32,856 million to INR40,686 million, outperforming the Indian pharmaceutical industry’s overall growth in sales in India, which grew at a CAGR of 5.78%.

The company is present in most of the major therapeutic areas, including, gynecology, cardiovascular, vitamins, minerals and nutrients, oncology/anti-neoplastic, HIV and blood-related. Across all such therapeutic areas, it is ranked among the top 10 pharmaceutical companies in India in terms of sales in India in the FY2021.

Promoters of Emcure Pharma – Satish Mehta and Sunil Mehta


Emcure Pharma IPO Details

Subscription DatesComing soon
Price BandINR – per share
Fresh issueINR1,100 crore
Offer For Sale18,168,356 shares
Total IPO sizeComing soon
Minimum bid (lot size)Coming soon
Face Value INR 10 per share
Retail Allocation35%
Listing OnNSE, BSE

Emcure Pharma’s Financial Performance

 FY2019FY2020FY2021
Revenue4,815.65,130.96,091.8
Expenses4,469.54,922.15,345.9
Net income236.8134.5 418.6
Margin (%)4.92.66.9
Figures in INR crore unless specified otherwise

Emcure Pharma IPO News


Emcure Pharma Valuations & Margins

FY2019FY2020FY2021
EPS10.474.6221.68
PE ratioNA
RONW (%)10.35 4.3717.25
ROCE (%) 14.8511.6722.64
EBITDA (%) 18.3215.3220.80
Debt/Equity
NAV101.15105.72125.68

Emcure Pharma IPO GMP Daily Trend

DateEmcure Pharma IPO GMPKostakSubject to Sauda

Emcure Pharma IPO Subscription – Live Updates

CategoryShares OfferedDay 1Day 2Day 3
QIB
NII
Retail
Employees
Total
Subscription figures in number of times, at 0:00 AM

Emcure Pharma IPO Reviews – Subscribe or Avoid?

Angel One –
Arihant Capital –
Ashika Research –
Asit C Mehta –
BP Wealth –
Canara Bank Securities –
Choice Broking –
Elite Wealth –
GEPL Capital –
Hem Securities –
ICICIdirect –
KR Choksey –
Marwadi Financial Services –
Motilal Oswal –
Nirmal Bang –
Religare Broking –
Samco Securities –
SMC Global –
Ventura Securities –


Emcure Pharma Offer Registrar

Link Intime India Private Limited 
C-101, 1st Floor,
247 Park, Lal Bahadur Shastri Marg,
Vikhroli (West), Mumbai 400 083,
Maharashtra, India
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: www.linkintime.co.in


Emcure Pharma Contact Details

Emcure Pharmaceuticals Limited
14th Floor, Tower 3, Plot No. P2, IT-BT Park
Phase II, M.I.D.C., Hinjawadi,
Pune – 411057,
Maharashtra, India
Phone: +91 22 7181 8181
Email: [email protected]
Website: www.emcure.com


Emcure Pharma IPO Allotment Status

Emcure Pharma IPO allotment will be available on Link Intime’s website. Click on this link to get allotment status.


Emcure Pharma IPO Timetable

IPO Opening DateComing soon
IPO Closing DateComing soon
Finalisation of Basis of AllotmentComing soon
Initiation of refundsComing soon
Transfer of shares to demat accountsComing soon
Listing DateComing soon
Opening Price on NSEComing soon
Closing Price on NSEComing soon

Emcure IPO FAQs

How many shares in Emcure Pharma IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply in Emcure Public Offer?

The best way to apply in Emcure IPO is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.

What is Emcure Pharma IPO GMP today?

Emcure Pharma IPO GMP today is NA per share.

What is Emcure IPO kostak rate today?

Emcure IPO kostak rate today is NA per application.

What is Emcure Pharma Subject to Sauda rate today?

Emcure Pharma Subject to Sauda rate today is NA per application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here